Chinese Medical Sciences Journal ›› 2016, Vol. 31 ›› Issue (3): 192-195.doi: 10.1016/S1001-9294(16)30050-5
• Reviews • Previous Articles Next Articles
Yue-wen Gao, Chun-hua Zhang, Xing-mei Zuo, Xi-zeng Hui*
Online:
2016-09-20
Published:
2016-09-20
Contact:
Tel: 86-18606330932, E-mail: Yue-wen Gao, Chun-hua Zhang, Xing-mei Zuo, Xi-zeng Hui. Genetic Basis of Gastric Cancer[J].Chinese Medical Sciences Journal, 2016, 31(3): 192-195.
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
1 | FujinoY, Tamakoshi A, Ohno Y, et al. Prospective study of educational background and stomach cancer in Japan. Prev Med 2002; 35:121-7. |
2 | Lazarevic K, Nagorni A, Rancic N, et al. Dietary factors and gastric cancer risk: hospital-based case control study. J Buon 2010; 15:89-93. |
3 | Nagini S. Carcinoma of the stomach: a review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol 2012; 4:156-69. |
4 | Wu XX, Li H, Zhao M. Medical Molecular Biology. Beijing: Science Press; 2009. p.303-4. |
5 | Kuniyasu H, Yasui W, Yokozaki H, et al. Aberrant expression of c-met mRNA in human gastric carcinomas. Int J Caneer 1993; 55:72-5. |
6 | Bao M, Wu JF. Expression of C-met in gastric carcinoma and its clinical significance. Anhui Med J 2012; 3:687-9. |
7 | Zhuang XQ, Lin SR, Zheng J, et al. Relationship between gastric lesions and c-met proto-oncogene expression and prognostic significance. Chin J Dig 2001; 21:116-7. |
8 | Ma GF, Cai HX, Ding FY, et al. Expression of c-Met in gastric cancer tissues and its clinical significance. Chin J Cancer Biother 2013; 20:603-8. |
9 | Motojima K, Furui J, Kohara N, et al. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection. Surgery 1994; 115:349-54. |
10 | Yonemura Y, Ninomiya I, Yamagudil A, et al. Evaluation of immunoreactivity of erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res 1991; 51:1034-8. |
11 | Shai AR, Zhao JS, Shang P, et al. The expression of C-erb-B2 cathepsin-D and its clinical significance in gastric cancer. J Diag Pathol 2002; 9:290. |
12 | Mei D, Liu Y, Hu F, et al. Expression and clinical significance of C-erb-B2 and Ki67 in gastric carcinoma. Chin J Microecol 2015; 27:828-30. |
13 | Lei J, Wang Z, Zhang H, et al. Lipopolysaccharide induced apoptosis in a murine intestinal endocrine cell line by modulation of Bcl-2, Bax and caspase-3. Mol Med Rep 2013; 8:1649-54. |
14 | Gobe G, Rubin M, Williams G, et al. Apoptosis and expression of Bcl-2, Bcl-XL, and Bax in renal cell carcinomas. Cancer Invest 2002; 20:324-32. |
15 | Chou HK, Chen SL, Hsu CT, et al. Bcl-2 accelerates retinoic acid-induced growth arrest and recovery in human gastric cancer cells. Biochem J 2003; 348:473-9. |
16 | Kim R, Emi M, Tanabe K, et al. Therapeutic potential of antisense Bcl-2 as a chemosentisizer for cancer therapy. Cancer 2004; 101:2491-502. |
17 | Zhu YJ, Qiu M, Zhou JT. Analysis of the p53 transcriptional activity in gastric cancer. Chin J Med Gene 2010; 27:60-6. |
18 | Yokobori T, Mimori K, Iwatsuki M, et al. p53-altered FBXW7 expression determines poor prognosis in gastric cancer cases. Cancer Res 2009; 69:3788-94. |
19 | Sirak I, Petera J, Hatlova J, et al. Expression of p53, p21 and p16 does not correlate with response to preoperative chemoradiation in gastric carcinoma. Hepatogastroenterology 2009; 56:1213-8. |
20 | Murakami K, Fujioka T, Kodama M, et al. Analysis of p53 mutations and Helicobacter pylori infection in human and animal models. Gastroenterol 2002; 37:1-5. |
21 | Grace A, Butler D, Gllagher M, et al. APC gene expression in gastric carcinorma: an immunohistochemical study. Appl Immunohistochem Mol Morphol 2002; 10:221-4. |
22 | Tamura G, Maesawa C, Suzuki Y, et al. Primary gastric carcinoma cells frequently lose heterozygosity at the APC and genetic loci. Jpn J Cancer Res 1993; 84:1015-8. |
23 | Wang JY, Hsieh JS, Chen CC, et al. Alterations of APC, c-met and P53 gene in tumor tissue and serum of patients with gastric cancers. J Surg Res 2004; 120:242-8. |
24 | Zhang Y, Zhai K, Jiang MJ, et al. The DCC mRNA expression and significance in gastric carcinoma. Shandong Med J 2015; 55:44-5. |
25 | Polvak K, Lee MH, Hediye EB, et al. Cloning of P27kipl, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular signals. Cell 1994; 78:59-66. |
26 | Toyoshima H, Hunter T. P27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to P21. Cell 1994; 78:67-74. |
27 | Cui Y, Zhang G, Li Z, et al. Role of p16 gene methylation in the pathogenesis of gastric cancer. J Clin Med Pract 2015; 19:49-51. |
28 | Wang M, Li Y, Gao J, et al. p16 methylation is associated with chemosensitivity to fluorouracil in patients with advanced gastric cancer. Med Oncol 2014; 31:988. |
29 | Sakellariou S, Liakakos T, Ghiconti I, et al. Immunohistochemical expression of P15 (INK4B) and SMAD4 in advanced gastric cancer. Anticancer Res 2008; 28:1079-83. |
30 | Cito L, Pentimalli F, Forte I, et al. Rb family proteins in gastric cancer. Oncol Rep 2010; 24:1411-8. |
[1] | Shu-bo Tian, Jian-chun Yu*, Wei-ming Kang, Zhi-qiang Ma, Xin Ye, Chao Yan, Ya-kai Huang. Effect of Neoadjuvant Chemotherapy Treatment on Prognosis of Patients with Advanced Gastric Cancer: a Retrospective Study [J]. Chinese Medical Sciences Journal, 2015, 30(2): 84-89. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
|
Supervised by National Health & Family Plan Commission of PRC
9 Dongdan Santiao, Dongcheng district, Beijing, 100730 China
Tel: 86-10-65105897 Fax:86-10-65133074
E-mail: cmsj@cams.cn www.cmsj.cams.cn
Copyright © 2018 Chinese Academy of Medical Sciences
All right reserved.
京公安备110402430088 京ICP备06002729号-1